- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Thursday, March 10, 2011
Register for our complimentary webinar:
* 10-11am ET session (convert time zone)
* Or 2-3pm ET session
* Can't make it? Request a recording instead
Microfluidics is honored to present guest speaker Robert Nicolosi, Ph.D., M.S., CNS, Professor and Director of the Center for Health & Disease Research at the University of Massachusetts (Lowell).
Professor Nicolosi is an experienced and innovative user of Microfluidizer high shear processing technology and continues to demonstrate breakthrough results using nanoemulsions to deliver oncology drugs and nutrients to the body.
His latest publication involving Microfluidics technology is entitled, "A Nanoemulsion Formulation of Dacarbazine Reduces Tumor Size in a Xenograft Mouse Epidermoid Carcinoma Model Compared to Dacarbazine Suspension" (S.Kakumanu, Tagne, Wilson and Nicolosi)
Register today (10am session or 2pm session) for a unique opportunity to interact with Professor Nicolosi as he details his acclaimed findings and ongoing work in pharmaceutical, nutraceutical and cosmeceutical delivery using nanoemulsions.
For more information, please click here
Copyright © MicrofluidicsIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Particle Works creates range of high performance quantum dots February 23rd, 2017
National Conference on Nanomaterials, (NCN-2017) April 21st, 2017
Nanomechanics, Inc. Unveils New Product at ICMCTF Show April 25th: Nanoindentation experts will launch the new Gemini that measures the interaction of two objects that are sliding across each other – not merely making contact April 21st, 2017
Forge Nano 2017: 1st Quarter Media Update April 20th, 2017